Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription


2 Ann Surg Oncol
1 BMC Cancer
5 Br J Cancer
1 Br J Surg
1 Cancer Lett
1 Dig Dis
2 Gastroenterology
1 Int J Cancer
8 Int J Colorectal Dis
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
3 Lancet Oncol
1 Oncogene
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. LI YJ, Yang CN, Kuo MY, Lai WT, et al
    ASO Visual Abstract: ATMIN Suppresses Metastasis by Altering the WNT Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10388.

  2. JOHNSTON FM, Yeo HL, Clark C, Stewart JH 4th, et al
    ASO Visual Abstract: Bias Issues in Colorectal Cancer Management-A Review.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10252.

    BMC Cancer

  3. WANG D, O'Rourke D, Sanchez-Garcia JF, Cai T, et al
    Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    BMC Cancer. 2021;21:797.
    PubMed         Abstract available

    Br J Cancer

  4. TEN HOORN S, Sommeijer DW, Elliott F, Fisher D, et al
    Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
    Br J Cancer. 2021 Jul 12. pii: 10.1038/s41416-021-01477.
    PubMed         Abstract available

  5. MORETTO R, Rossini D, Conca V, Lonardi S, et al
    CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
    Br J Cancer. 2021 Jul 12. pii: 10.1038/s41416-021-01483.
    PubMed         Abstract available

  6. WANG X, Liu Q, Halfdanarson OO, Zoega H, et al
    Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.
    Br J Cancer. 2021 Jul 12. pii: 10.1038/s41416-021-01480.
    PubMed         Abstract available

  7. ZOLTICK ES, Smith-Warner SA, Yuan C, Wang M, et al
    Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival.
    Br J Cancer. 2021 Jul 15. pii: 10.1038/s41416-021-01487.
    PubMed         Abstract available

  8. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed         Abstract available

    Br J Surg

  9. EBBEHOJ AL, Jorgensen LN, Krarup PM, Smith HG, et al
    Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis.
    Br J Surg. 2021 Jul 9. pii: 6304963. doi: 10.1093.
    PubMed         Abstract available

    Cancer Lett

  10. STADLER M, Pudelko K, Biermeier A, Walterskirchen N, et al
    Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
    Cancer Lett. 2021;520:184-200.
    PubMed         Abstract available

    Dig Dis

  11. LONGCHAMP G, Meyer J, Abbassi Z, Sleiman M, et al
    Current Surgical Strategies for the Treatment of Rectal Adenocarcinoma and the Risk of Local Recurrence.
    Dig Dis. 2021;39:325-333.
    PubMed         Abstract available


  12. LIU MC, Anderson JC
    Long-Term Outcomes of Patients with Serrated Polyposis Syndrome.
    Gastroenterology. 2021;160:962-964.

  13. KIM H, Lipsyc-Sharf M, Zong X, Wang X, et al
    Total vitamin D intake and risks of early-onset colorectal cancer and precursors.
    Gastroenterology. 2021 Jul 7. pii: S0016-5085(21)03235.
    PubMed         Abstract available

    Int J Cancer

  14. WATTS K, Wills C, Madi A, Palles C, et al
    Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.
    Int J Cancer. 2021 Jul 16. doi: 10.1002/ijc.33739.
    PubMed         Abstract available

    Int J Colorectal Dis

  15. IWASA Y, Koyama F, Marugami N, Kuge H, et al
    The middle rectal artery detected by contrast-enhanced magnetic resonance imaging predicts lateral lymph node metastasis in lower rectal cancer.
    Int J Colorectal Dis. 2021;36:1677-1684.
    PubMed         Abstract available

  16. AUBERT M, Mege D, Billiauws L, Joly F, et al
    State-of-the-art colorectal disease: conservative surgical management of intestinal failure in adults.
    Int J Colorectal Dis. 2021;36:1597-1607.
    PubMed         Abstract available

  17. GAROFALO E, Selvaggi F, Spinelli A, Pellino G, et al
    Surgical management of complex ileocolonic Crohn's disease: a survey of IBD colorectal surgeons to assess variability in operative strategy.
    Int J Colorectal Dis. 2021;36:1811-1815.
    PubMed         Abstract available

  18. ANANIA G, Arezzo A, Davies RJ, Marchetti F, et al
    A global systematic review and meta-analysis on laparoscopic vs open right hemicolectomy with complete mesocolic excision.
    Int J Colorectal Dis. 2021;36:1609-1620.
    PubMed         Abstract available

  19. SPONHOLZ S, Oguzhan S, Mese M, Schirren M, et al
    The impact of primary tumor location on prognosis after colorectal lung metastasectomy.
    Int J Colorectal Dis. 2021;36:1731-1737.
    PubMed         Abstract available

  20. PANG K, Sun P, Li J, Zeng N, et al
    Prophylactic subcutaneous drainage reduces post-operative incisional infections in colorectal surgeries: a meta-analysis of randomized controlled trials.
    Int J Colorectal Dis. 2021;36:1633-1642.
    PubMed         Abstract available

  21. PENG J, Lv J, Peng J
    KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.
    Int J Colorectal Dis. 2021;36:1781-1790.
    PubMed         Abstract available

  22. UTSUMI M, Matsuda T, Yamashita K, Hasegawa H, et al
    Short-term and long-term outcomes after laparoscopic surgery for elderly patients with colorectal cancer aged over 80 years: a propensity score matching analysis.
    Int J Colorectal Dis. 2021 Jul 12. pii: 10.1007/s00384-021-03973.
    PubMed         Abstract available

    J Clin Oncol

  23. SHI DD, Mamon HJ
    Playing With Dynamite? A Cautious Assessment of TNT.
    J Clin Oncol. 2021;39:103-106.

    J Natl Cancer Inst

  24. UGAI T, Vayrynen JP, Haruki K, Akimoto N, et al
    Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates.
    J Natl Cancer Inst. 2021 Jul 15. pii: 6321960. doi: 10.1093.
    PubMed         Abstract available

    J Surg Oncol

  25. TODATE Y, Honda M, Takada T, Saginoya T, et al
    The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
    J Surg Oncol. 2021 Jul 14. doi: 10.1002/jso.26602.
    PubMed         Abstract available

    Lancet Oncol

  26. CONROY T, Castan F, Gourgou S, Marchal F, et al
    Intensifying neoadjuvant treatment in locally advanced rectal cancer - Authors' reply.
    Lancet Oncol. 2021;22:e302.

    A step closer to a personalised approach for Lynch syndrome.
    Lancet Oncol. 2021;22:899-901.

  28. PATEL S, Kapoor A
    Intensifying neoadjuvant treatment in locally advanced rectal cancer.
    Lancet Oncol. 2021;22:e301.


  29. KOBELT D, Perez-Hernandez D, Fleuter C, Dahlmann M, et al
    The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01917.
    PubMed         Abstract available

    PLoS One

  30. VANACLOCHA-ESPI M, Ibanez J, Molina-Barcelo A, Valverde-Roig MJ, et al
    Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.
    PLoS One. 2021;16:e0254021.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.